Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (131-140 of 13,976) with videos related to

Pageof 1,398
Sort By:
Leukemia|April 7, 2011
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidineR Itzykson, S Thépot, V Eclache, et al.
Leukemia|March 5, 2011
Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemiaG Escherich, S Richards, L C Stork, et al.
Leukemia|July 1, 1990
Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemiaK Tobal, A Pagliuca, B Bhatt, et al.
Leukemia|June 9, 2019
High circulating levels of MPO-DNA are associated with thrombosis in patients with MPNAlexandre Guy, Simon Favre, Sylvie Labrouche-Colomer, et al.
Leukemia|October 14, 2018
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myelomaReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Leukemia|October 14, 2018
Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studiesMegan Othus, Mikkael A Sekeres, Sucha Nand, et al.
Leukemia|October 14, 2018
Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosisNatasha Szuber, Terra L Lasho, Christy Finke, et al.
Leukemia|October 14, 2018
Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cellsKrista Kinneer, Matt Flynn, Suneetha B Thomas, et al.
Leukemia|October 14, 2018
CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cellsMarion Alcantara, Melania Tesio, Carl H June, et al.
Leukemia|October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaG Fraser, P Cramer, F Demirkan, et al.
Pageof 1,398

Showing results (131-140 of 13,976) with videos related to

Sort By:
Pageof 1,398
Leukemia|April 7, 2011
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidineR Itzykson, S Thépot, V Eclache, et al.
Leukemia|March 5, 2011
Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemiaG Escherich, S Richards, L C Stork, et al.
Leukemia|July 1, 1990
Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemiaK Tobal, A Pagliuca, B Bhatt, et al.
Leukemia|June 9, 2019
High circulating levels of MPO-DNA are associated with thrombosis in patients with MPNAlexandre Guy, Simon Favre, Sylvie Labrouche-Colomer, et al.
Leukemia|October 14, 2018
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myelomaReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Leukemia|October 14, 2018
Relative survival following response to 7 + 3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes: an analysis of four SWOG studiesMegan Othus, Mikkael A Sekeres, Sucha Nand, et al.
Leukemia|October 14, 2018
Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosisNatasha Szuber, Terra L Lasho, Christy Finke, et al.
Leukemia|October 14, 2018
Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cellsKrista Kinneer, Matt Flynn, Suneetha B Thomas, et al.
Leukemia|October 14, 2018
CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cellsMarion Alcantara, Melania Tesio, Carl H June, et al.
Leukemia|October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaG Fraser, P Cramer, F Demirkan, et al.
Pageof 1,398